Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.23
NASDAQLPCN
Open
$1.27
Change
-$0.03 (-2.38%)
Day's Range
$1.18 - $1.32
52-Week Range
$0.31 - $3.46
Volume
1.9M
Market Cap
$58.9M